NANOBAC PHARMACEUTICALS, INCORPORATED Quotes Nanobac Pharmaceuticals, Incorporated
Equities
NNBP
US63007M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | 0.00% |
Volumes
marketsDaily volume
1 000
Estimated daily volume
1 000
Avg. Volume 20 sessions
1 000
Daily volume ratio
1.00
Avg. Volume 20 sessions USD
0.00
Record volume 1
84 350 730
Record volume 2
58 195 380
Record volume 3
55 925 900
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
249
Net sales (USD)
17 621
Free-Float
100 %
Free-Float capitalization (USD)
249
Average Daily Capital Traded
0%
Highs and lows
3 years
0.00
0.00
5 years
0.000.01
10 years
0.000.01
Indicators
RSI 9 days
54.37
RSI 14 days
55.73
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 249 | ||
| +2.11% | +5.99% | +29.03% | -0.76% | 49.18B | ||
| +0.92% | +0.87% | -0.10% | +22.83% | 42.11B | ||
| +2.62% | -1.29% | +46.90% | -11.09% | 40.37B | ||
| +0.05% | -1.80% | -5.26% | +14.59% | 28.85B | ||
| +1.96% | +0.33% | +11.48% | +57.78% | 26.09B | ||
| -1.33% | -4.17% | -22.74% | -27.99% | 18.71B | ||
| +2.66% | +8.64% | +9.06% | +3.51% | 13.26B | ||
| +2.38% | -0.89% | +30.01% | +90.73% | 12.32B | ||
| +1.93% | -1.47% | -1.51% | +21.74% | 11.99B | ||
| +2.06% | +1.34% | +22.69% | +26.05% | 11.97B | ||
| +2.39% | +5.68% | +1.38% | -2.35% | 10.07B | ||
| +1.17% | +6.34% | +32.92% | -10.88% | 7.05B | ||
| -2.40% | -2.85% | +14.33% | +95.22% | 6.6B | ||
| +2.60% | -4.08% | +7.66% | -33.68% | 6.59B | ||
| +0.56% | -3.86% | +30.33% | +44.49% | 6.17B | ||
| Average | +1.22% | +0.50% | +13.75% | +19.35% | ||
| Weighted average by Cap. | +1.46% | +0.84% | +14.97% | +14.41% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | 0.00% | ||
| 2023 | 0.00% | ||
| 2022 | 0.00% | ||
| 2021 | -99.75% | ||
| 2020 | +33.33% | ||
| 2019 | 0.00% | ||
| 2018 | -50.17% | ||
| 2017 | +201.00% | ||
| 2016 | +81.82% | ||
| 2015 | -78.00% | ||
| 2014 | -16.67% | ||
| 2013 | -25.00% | ||
| 2012 | -42.86% | ||
| 2011 | -44.00% | ||
| 2010 | +177.78% | ||
| 2009 | -88.75% | ||
| 2008 | -83.33% | ||
| 2007 | -60.00% | ||
| 2006 | +224.32% | ||
| 2005 | -74.48% | ||
| 2004 | -78.99% | ||
| 2003 | +38.00% |
- Stock Market
- Equities
- NNBP Stock
- Quotes Nanobac Pharmaceuticals, Incorporated